Tonix Pharmaceuticals appoints Irina Ishak as General Counsel effective Dec 8, 2025

Tonix Pharmaceuticals Holding Corp.

Irina Ishak joins from Lowenstein Sandler LLP where she was Senior Counsel since 2013.
She previously advised Tonix since 2017 on financings, licensing, and corporate governance.
Ms. Ishak brings over 25 years of legal experience in life sciences, including at Savient Pharmaceuticals.
Tonix recently launched TONMYA for fibromyalgia, first new FDA-approved treatment in over 15 years.
Seth Lederman, CEO, highlights her expertise in complex transactions and public company matters.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.